Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ·Healthcare·Biotechnology
$461.71
+1.89%
Mkt Cap $112.92B
Analyst Ratings
Buy
25
Hold
4
Sell
0
Price Target (85 analysts)
$549.73
Range $441.00 – $607.00
Implied Upside
+19.1%
Consensus $549.73 vs current $461.71